Novo Nordisk cuts Ozempic, Wegovy prices
COPENHAGEN, Feb. 24 – Novo Nordisk said it will cut U.S. list prices for its blockbuster weight-loss drug Wegovy and diabetes treatment Ozempic effective Jan. 1, 2027, lowering the monthly…
Ethical Objective Balanced Sentinel
Where truth stands guard
COPENHAGEN, Feb. 24 – Novo Nordisk said it will cut U.S. list prices for its blockbuster weight-loss drug Wegovy and diabetes treatment Ozempic effective Jan. 1, 2027, lowering the monthly…
WASHINGTON — The Food and Drug Administration said a television advertisement for Novo Nordisk’s Wegovy weight‑loss pill is “false or misleading,” citing an agency letter dated Feb. 5 that flagged…